CD163 and neoplasm: Figure 5 presents images of tumor tissue stained with CD8 (marker of killer T cells), F4/80 (marker of M1 and M2 macrophages), and CD163 (marker of M2 macrophages) antibodies ten days after administrating B16-F10 OVA cells.